Delivery Order SPE2DB22D2006-SPE2DB26FV5SS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,105.45 to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Naropin 1% (200 mg/20 mL vials). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 17, 2025. This delivery order is issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division located in Conshohocken, Pennsylvania. The firm fixed price contract, valued at $1,067.09, is for the provision of 150 mg/30 mL vials of the anesthetic drug Naropin 0.5% with an ultimate completion date of March 22, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a leading global pharmaceutical sourcing and...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price, valued at $2,665.86, for the supply of a pharmaceutical product, NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,361.71 firm fixed-price delivery order covers the supply of NAROPIN 0.2% 400 MG/200 ML BTL 200ML, a specialty pharmaceutical product, with a performance period ending on August 30, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- The Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FEKV1, valued at $2,638.47, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This firm fixed price delivery order is for the supply of 4564230198 NAROPIN 0.5% 150 MG/30 ML VIAL 30ML to support military treatment programs and facilities. The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp, which has a potential value of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,668.07 and is a Firm Fixed Price Delivery Order with a completion date of May 16, 2024. It is not designated as a set-aside contract. The contract covers the procurement of 4564614741 ! NAROPIN 1% 200 MG/20 ML VIAL 20ML, a pharmaceutical product. AmerisourceBergen holds a significant...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 150 mg/20 ml vials of the pharmaceutical product NAROPIN 0.75% in support of military treatment programs and facilities. The order has a potential value of $1,580.06 and a completion date of January 24, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime...
- This federal contract award is for the delivery of NAROPIN 0.2% 400 MG/200 ML BTL 200ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract, valued at $5,214.94, was awarded on September 21, 2022, with a completion date of September 22, 2022. It is a delivery order contract with a firm fixed price pricing type. The...
- The Defense Logistics Agency awarded a $284.80 delivery order to Amerisourcebergen Drug Corporation for 4561422593 NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for delivery of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania. Performance will take place between July 6-7, 2023. As the logistics and procurement arm of the Department of Defense, the Defense Logistics...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB26FV5SSDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,013.55 for Naropin 0.5% (150 mg/30 mL vial) with an ultimate completion date of October 16, 2025. This firm fixed price, non-set-aside contract was competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle that runs through December 2026. AmerisourceBergen Drug Corp serves as a critical federal medical procurement vendor, supplying a comprehensive range of pharmaceutical products to military and veteran healthcare systems through the DLA Medical Supply Chain. The parent IDC enables the company to fulfill orders across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for the local anesthetic Naropin reflects the company's role as a primary vendor in the federal medical supply network, delivering essential pharmaceuticals to support military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/15/25 |